- Home
- NAMS vs LGND Comparison
NAMS vs LGND Comparison
Compare NAMS & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAMS
- LGND
- Stock Information
- Founded
- NAMS 2019
- LGND 1987
- Country
- NAMS Netherlands
- LGND United States
- Employees
- NAMS N/A
- LGND 68
- Industry
- NAMS Biotechnology: Pharmaceutical Preparations
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- NAMS Health Care
- LGND Health Care
- Exchange
- NAMS Nasdaq
- LGND Nasdaq
- Market Cap
- NAMS 3.1B
- LGND 3.2B
- IPO Year
- NAMS N/A
- LGND 1992
- Fundamental
- Price
- NAMS $36.14
- LGND $189.97
- Analyst Decision
- NAMS Strong Buy
- LGND Strong Buy
- Analyst Count
- NAMS 10
- LGND 8
- Target Price
- NAMS $43.70
- LGND $144.71
- AVG Volume (30 Days)
- NAMS 1.4M
- LGND 139.7K
- Earning Date
- NAMS 11-06-2025
- LGND 08-05-2025
- Dividend Yield
- NAMS N/A
- LGND N/A
- EPS Growth
- NAMS N/A
- LGND N/A
- EPS
- NAMS N/A
- LGND N/A
- Revenue
- NAMS $64,006,000.00
- LGND $181,488,000.00
- Revenue This Year
- NAMS N/A
- LGND $18.41
- Revenue Next Year
- NAMS $1.67
- LGND $18.87
- P/E Ratio
- NAMS N/A
- LGND N/A
- Revenue Growth
- NAMS 762.15
- LGND 53.40
- 52 Week Low
- NAMS $14.06
- LGND $81.74
- 52 Week High
- NAMS $41.47
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- NAMS 60.09
- LGND 70.92
- Support Level
- NAMS $34.34
- LGND $179.00
- Resistance Level
- NAMS $37.21
- LGND $187.81
- Average True Range (ATR)
- NAMS 2.47
- LGND 5.07
- MACD
- NAMS -0.34
- LGND -0.24
- Stochastic Oscillator
- NAMS 46.32
- LGND 92.25
About NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.